Medibank Private Ltd
ASX:MPL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.73
5.26
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
MPL
stock under the Base Case scenario is
4.52
AUD.
Compared to the current market price of 4.77 AUD,
Medibank Private Ltd
is
Overvalued by 5%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Medibank Private Ltd.
| ZA |
S
|
Sanlam Ltd
JSE:SLM
|
|
| CN |
|
China Life Insurance Co Ltd
SSE:601628
|
|
| CN |
|
Ping An Insurance Group Co of China Ltd
SSE:601318
|
|
| ZA |
D
|
Discovery Ltd
JSE:DSY
|
|
| HK |
|
AIA Group Ltd
HKEX:1299
|
|
| ZA |
O
|
OUTsurance Group Ltd
JSE:OUT
|
|
| ZA |
O
|
Old Mutual Ltd
JSE:OMU
|
|
| CA |
|
Manulife Financial Corp
TSX:MFC
|
|
| IN |
|
Life Insurance Corporation Of India
NSE:LICI
|
|
| US |
|
Aflac Inc
NYSE:AFL
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Medibank’s costly and high-profile 2022 data breach may erode consumer trust in its brand, creating potential churn and putting downward pressure on membership growth.
Stringent regulatory oversight by the Australian government, including restrictions on premium increases and policy benefits, could compress Medibank’s margins and limit pricing power.
Heightened competition from smaller, more agile health insurance providers offering tech-driven solutions and niche coverage could undermine Medibank’s market share over time.
Medibank’s dominant market share and strong brand recognition position it to capture ongoing industry tailwinds, such as an aging population seeking private health coverage.
The company’s focus on health management and digital wellness initiatives may drive customer engagement, potentially translating into higher retention rates and more stable underwriting results.
Strong balance sheet and consistent free cash flow generation give Medibank flexibility to invest in growth opportunities, healthcare partnerships, and potential acquisitions.
Balance Sheet Decomposition
Medibank Private Ltd
| Cash & Short-Term Investments | 648.6m |
| Insurance Receivable | 66.4m |
| PP&E | 194.2m |
| Long-Term Investments | 3.1B |
| Other Assets | 689.6m |
| Insurance Policy Liabilities | 1.8B |
| Short Term Debt | 35m |
| Long Term Debt | 144.8m |
| Other Liabilities | 430.7m |
Wall St
Price Targets
MPL Price Targets Summary
Medibank Private Ltd
According to Wall Street analysts, the average 1-year price target for
MPL
is 5.33 AUD
with a low forecast of 4.75 AUD and a high forecast of 6.13 AUD.
Dividends
Current shareholder yield for
MPL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MPL
stock under the Base Case scenario is
4.52
AUD.
Compared to the current market price of 4.77 AUD,
Medibank Private Ltd
is
Overvalued by 5%.